Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
A subject was treated under compassionate use provisions under this study with facilitating cell therapy (FCRx) product manufactured using the CliniMACS (Miltenyi Biotec) device, rather than the Max Sep (Baxter) device.
Epistemonikos ID: 67cb9be015106529673e499ae03df67f70e74e8b
First added on: May 11, 2024